KING PHARMA ACQUIRES AVINZA FROM LIGAND

King Pharmaceuticals, Inc. has entered into a definitive asset purchase agreement and related agreements with Ligand Pharmaceuticals Incorporated to acquire rights to Avinza (morphine sulfate extended release). Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=35044)